Tag: cx 2019

The benefit of early ankle-brachial pressure index measurement for vascular wound...

CX Executive Board member Una Adderley (Wakefield, UK), director of the National Wound Care Strategy Programme for the National Health Service (NHS) England, spoke...

The increasing importance of interdisciplinary wound care

Keith Harding advocates for the increased involvement of medical staff in the treatment of patients with wound healing difficulties, as the number of chronic...

Virtual reality stimulates discussion at CX

For the first time, the audience at the 2019 Charing Cross Symposium (CX; 15–18 April, London, UK) was able to experience an array of...

iWounds Workshop debut at CX 2019

The 2019 Charing Cross Symposium (CX; 15–18 April, London, UK) saw the introduction of a new strand of care with the debut of the...

Endoanchors add to therapy options for AAA

Using EndoAnchors to fix and seal endovascular aortic grafts is safe and effective for short-neck abdominal aortic aneurysm (AAA) patients, two-year data from the...

ACTION trial finds ACT-guided heparinisation increases patient safety

Implementing a method of heparinisation guided by activated clotting time (ACT), with a goal of 200–220 seconds, provides a “promising” increase in safety and...

Off-the-shelf T-branch saves lives in emergency cases

An off-the-shelf endograft for the treatment of thoracoabdominal aortic aneurysms (TAAA) provides a safe and straightforward solution for a wide range of patients—including emergency...

Late rupture after EVAR is rare but incidence is increasing

At the 2019 Charing Cross Symposium (CX; 15–18 April, London, UK), Vincenzo Brizzi (Bordeaux, France) reported the 10-year results for late rupture after endovascular...

Design of Valiant Navion “improves upon current-generation TEVAR”

In the Aortic Podium 1st session at the 2019 Charing Cross Symposium (CX; 15–18 April, London, UK), Fabio Verzini (Turin, Italy) reported the 30-day...

Defining success in wound healing: “Ambiguous and difficult to define”

Defining success in wound healing remains a nebulous concept, with no consensus on what constitutes a successful outcome. Dave Bosanquet (Bristol, UK) outlined the...

The impact of paclitaxel concerns on vascular access

At the 2019 Charing Cross Symposium (CX; 15–18 April, London, UK), there was a section of the programme on drug-coated balloon trial updates which...

The role of surveillance in thrombosis treatment

As part of the CX Vascular Access Masterclass on Wednesday, Colin Deane (London, UK) considered the role of surveillance in thrombosis, asking whether there...

Proximal neck sealing does not seem to induce neck dilatation

Endovascular aneurysm repair (EVAR) using proximal polymer sealing does not seem to induce neck dilatation like other endografts, concluded Hence Verhagen (Rotterdam, The Netherlands)...

Coil embolisation improves EVAR results for high risk patients

Coil embolisation for at-risk patients during endovascular aneurysm repair (EVAR) is a safe and reproducible procedure, Dominique Fabre (Le Plessis-Robinson, France) told delegates at...

Vascular recruitment a “universal problem”: The global perspective

Across the globe, vascular recruitment is struggling. This was the reason why delegates convened at the 2019 Charing Cross Symposium (CX; 15–18 April, London,...

CX showcases the best of modern endovascular technology with virtual reality...

Yesterday’s CX Highlight Session on the durability of endovascular aneurysm repair (EVAR) and the National Institute for Health and Care Excellence (NICE) aortic guidelines...

The vascular community should “be more critical” about accepting new technologies...

Isaac Nyamekye (Worcester, UK) reported that compared with the Venefit and radiofrequency induced thermotherapy (RFITT) systems, endovascular radiofrequency ablation (EVRF) provided inferior truncal ablation...

Three key tips for managing aortic graft infections

Xavier Berard (Bordeaux, France) gave delegates at the 2019 Charing Cross Symposium (CX; 15–18 April, London, UK) three fundamental principles to bear in mind...

Peripheral and Aortic Workshops give CX delegates practical experience and expert...

During the CX Peripheral and Aortic Workshops at the 2019 Charing Cross Symposium (CX; 15–18 Aprril, London, UK), experts demonstrated a wide range of...

CX Aortic Techniques & Technologies highlights Best of Aortic Live and...

The 2019 Charing Cross Symposium (CX; 15–18 April, London, UK) featured an Aortic Techniques & Technologies edited live cases session, which aimed to give...

CEC@CX

In collaboration with the China Endovascular Course (CEC), this year’s Charing Cross Symposium (CX; 15–18 April, London, UK) played host to CEC@CX. Wei Guo (Beijing,...
patient-level

Cook Medical releases patient-level data from Zilver PTX paclitaxel-eluting stent study

Cook Medical has released de-identifiable patient-level data from a clinical trial of its Zilver PTX peripheral paclitaxel-eluting stent. The move comes a month after the...

Multicentre dataset reveals the added value of diffusion-weighted imaging in TEVAR...

Novel data from the Stroke from Thoracic Endovascular Procedures (STEP) study has provided insight into current practice of thoracic endovascular aortic repair (TEVAR), and...

Hear the latest thoughts on paclitaxel from global experts: Their current...

 Following the latest information presented at the Charing Cross (CX) International Symposium related to the meta-analysis of paclitaxel-coated devices (Katsanos et al), hear from a...

Study argues ambulatory office-based treatment is possible for high-risk patients

Office-based lower extremity arterial interventions are feasible, safe, and cost-effective, and provide high levels of patient satisfaction. Enrico Ascher (Brooklyn, USA) presented data that...
Venous ulceration

“Urgent action is required for patients with venous ulceration”

Despite what current guidelines denote, and in addition to the emergence of data supporting the early intervention of venous ulceration, Alun Davies (London, UK)...
VenaSeal

VenaSeal maintains safety and efficacy at extended five-year follow-up

The first-ever 60-month data on Medtronic’s VenaSeal closure system were presented on Tuesday, indicating that at five years, treatment with the cyanoacrylate adhesive for...
paclitaxel

While CX audience deems paclitaxel not dangerous, vascular pathologist says establishing...

Delegates voted overwhelmingly against the notion that there was a demonstrable danger in any organ of the body attributed to circulating paclitaxel. These polling...

EVAR funding threatened, while strategy for safe, cost-effective repair is “just...

The durability of endovascular aneurysm repair (EVAR) is in the limelight as the UK vascular community awaits the final aortic aneurysm guidelines from the...
helical

New MIMICS-2 trial data show helical stents provide durable treatment of...

New data from the MIMICS-2 trial show the BioMimics 3D stent, which mimics natural vascular curvature, remains safe and effective for patients with symptomatic...
paclitaxel

Paclitaxel-releasing devices: An unfolding story

Paclitaxel Timeline: Meta-analysis finds a higher risk of death in the long term when paclitaxel-coated devices are used in the leg Without additional long-term...

CX 2019 to host first-ever aortic and peripheral virtual reality live...

The Charing Cross International Symposium (CX) continues its three-year cycle of raising vascular and endovascular controversies in order to challenge the available evidence and...

CX 2019 Aortic Challenges Programme Highlights

 Stéphan Haulon, member of the CX Aortic Executive Board looks ahead to CX 2019 and raises some of the key questions that will be...